Burberry, the luxury goods group, is expected to maintain its strong momentum by posting a sharp uplift in second-half sales today. Burberry's shares - which are up by more than 60% in the past year - have also been buoyed by persistent bid speculation. Given the valuation of 21 times forward earnings for 2012, we think such a takeover scenario is unlikely. This reinforces the Independent's view that Burberry's shares are well worth buying, but only when they have cooled down a bit. Hold, the newspaper recommends.Acta is involved in the research, development and commercialisation of products for renewable energy, carbon-free motoring and battery applications. Acta was put off balance recently by what seemed to be a re-writing of the tariff rules in the Italian solar power market. This will result, it is estimated, in a revenue reduction of around €3.4m (£3m) for the company. Investors prepared to take the risk in anticipating a successful conclusion to the tariff debate could benefit from the removal of something of a barrier to Acta's share price. The Scotsman says buy.Jupiter's quarterly figures were welcomed by the market yesterday, and rightly so. The fund manager attracted net inflows of £333m, with increased interest from international investors and strong demand for its fund-of-fund range. The first quarter's net inflows are an encouraging sign in the current volatile investment world. They may look a little disappointing compared with earlier quarters, but the lower figure is simply a reflection of the more challenging times faced by the industry. Buy, says the Independent.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.Primary Health Properties invests in GP surgeries and pharmacies with long leases with a view to generating solid, long-term income streams. This investment is therefore an income play with the added sweetener of long-term capital appreciation. The shares remain a buy for income seekers because of the rising yield, says the Telegraph.Shares in Mozambique-based titanium miner Kenmare have performed extremely well over the last few months - and yesterday's full-year numbers underscored why. Kenmare operates the Moma titanium mine in the southern African country - and prices of the commodity which is mainly used in white pigments have been rising. After a strong run investors may want to top slice this investment and sell half of their holding, but the Telegraph's rating remains buy.---RG